Case report reveals novel pathogenic variants in B4GALT1-CDG, implying genetic testing is essential for diagnosing dual rare diseases.
This case highlights the complexity of diagnosing dual rare metabolic diseases and the importance of genetic testing in uncovering novel pathogenic variants. It has also contributed to expanding the clinical manifestation spectrum of B4GALT1-CDG, which is an ultra-rare disorder.
No takes yet. Share an insight, caveat, or question.
Esra Deniz Papatya Çakır (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: